683 Capital Management »

Clearpoint Neuro shares owned by 683 Capital Management

Quarter-by-quarter ownership of Clearpoint Neuro (CLPT) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Clearpoint Neuro

Tip: Access up to 7 years of quarterly data

All positions including Clearpoint Neuro held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Clearpoint Neuro by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $837k 54k 15.38
2023-03-31 $163k 19k 8.44
2022-12-31 $164k 19k 8.47
2020-12-31 $329k 21k 15.90

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Clearpoint Neuro

BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
UBS Group
Morgan Stanley
Brown Advisory Holdings Incorporated
Lane Generational
Two Sigma Investments
Boone Capital Management
Citadel Advisors
Susquehanna International
Essex Investment Management
Deutsche Bank Aktiengesellschaft
Eudaimonia Asset Management

View all funds holding Clearpoint Neuro